In-Person Access Only | 1.75 CME Credits

Please read: All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $25 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team.

The 2027 Cancer Updates GI and Breast Boston Conference will consist of educational activities designed to meet the needs of medical oncologists, pharmacists, advanced practitioners, and nurses involved in the treatment of GI and Breast cancers. Each program agenda is comprised of presentations that will break down the most clinically relevant information applicable to community care. This dinner program will be hosted as an in-person event only.

Conference Agenda
Thursday, October 14, 2027

Program Chairs:
TBD

5:30 PM
Networking and Cocktails

6:00 PM
Welcome and Opening Remarks

6:05 PM
GI Cancer Updates

6:35 PM
GI Panel Discussion

6:55 PM
Dinner and Exhibits

7:10 PM
Non-CME

7:55 PM
Breast Cancer Updates

8:20 PM
Breast Cancer Panel Discussion

8:45 PM
ADJOURN

‍ ‍ Agenda Subject To Change. All times are EST.

• Learning Objectives

  • Free registration for all healthcare providers

  • Expert sessions that present the most clinically relevant data, research, and clinical strategies

  • Real-time discussion and debate

  • Networking with peers, colleagues, and medical professionals

  • Access to the latest industry information and resources

  • Catered meals through-out the program

• Accreditation Information

• What to Expect | In-Person Learners

  • Review recent clinical advances in the treatment of gastrointestinal (GI) and breast cancers, with a focus on the most relevant data from recent studies and clinical trials.

  • Evaluate the role of emerging therapies in GI and breast cancer treatment, including new medications, targeted therapies, and immunotherapies.

  • Apply evidence-based strategies to improve patient outcomes in community oncology settings, focusing on the integration of new treatment approaches.

  • Assess and manage side effects and toxicities associated with current and emerging therapies in GI and breast cancer patients.

  • Discuss multidisciplinary care approaches that enhance collaboration between oncologists, pharmacists, nurses, and advanced practitioners in treating GI and breast cancers.